Effects of Intermittent Fasting on Response to Tyrosine Kinase Inhibitors (TKIs) in Patients With Chronic Myeloid Leukemia: An Outcome of European LeukemiaNet Project

Effects of Intermittent Fasting on Response to Tyrosine Kinase Inhibitors (TKIs) in Patients With Chronic Myeloid Leukemia: An Outcome of European LeukemiaNet Project

The overall survival of patients with Chronic Myeloid Leukemia (CML) treated by using tyrosine kinase inhibitors (TKIs) is very close to that of the healthy population. However, little is known about the effect of specific measures such as intermittent fasting, especially during Ramadan period. A 3-...

Full description

Bibliographic Details
Main Authors:	Mohamed A. Yassin MBBS, MSc, Rola S. Ghasoub BSC, Mahmood B. Aldapt MD, Mohammad A. Abdulla MD, Prem Chandra PhD, Hawraa M. Shwaylia MD, Abdulqadir J. Nashwan BSN, MSN, Nancy A. Kassem BSC, Susanna J. Akiki PhD
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-04-01
Series:	Cancer Control
Online Access:	https://doi.org/10.1177/10732748211009256

Similar Items

A three-gene expression-based risk score can refine the European LeukemiaNet AML classification
by: Stefan Wilop, et al.
Published: (2016-09-01)

Acute Myeloid Leukemia With Presenting as Severe Hepatic Failure
by: Yoshiko Nakano MD, et al.
Published: (2017-01-01)

Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront
by: Husam N. Al-Dubai, et al.
Published: (2020-06-01)

Chronic myeloid leukaemia in the South African public health setting: Are we reaching the European LeukemiaNet targets for frontline therapy?
by: Tshifhiwa B. Sikhipha, et al.
Published: (2020-12-01)

Ophthalmologic Manifestations as Initial Presentation of Patients with Chronic Myeloid Leukemia: Report of Two Cases
by: Shehab F. Mohamed, et al.
Published: (2020-01-01)

Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer: Case Report
by: Shehab F. Mohamed, et al.
Published: (2019-12-01)

The new European leukemianet recommendations for treating CML
by: Rüdiger Hehlmann
Published: (2020-10-01)

Outcome of Pregnancy in the Era of PEGylated Interferon-α2a in Females with Chronic Myeloid Leukemia: An Experience from Qatar
by: Mohammad Abu-Tineh, et al.
Published: (2020-03-01)

Chronic Myeloid Leukemia Preceded by Tuberculosis
by: Bara M. Al-Qudah, et al.
Published: (2020-06-01)

Aortic Stenosis and the Tyrosine Kinase Inhibitor Nilotinib in Chronic Myeloid Leukemia
by: Miguel Carracedo, PhD, et al.
Published: (2020-03-01)

Metformin Prolongs Survival in Type 2 Diabetes Lung Cancer Patients With EGFR-TKIs
by: Ming-Szu Hung MD, PhD, et al.
Published: (2019-08-01)

Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines
by: Yu Kang, MD, PhD, et al.
Published: (2019-12-01)

How I treat obesity and obesity related surgery in patients with chronic myeloid leukemia: An outcome of an ELN project
by: Mohamed A. Yassin, et al.
Published: (2021-03-01)

Assessment of Dasatinib Versus Nilotinib as Upfront Therapy for Chronic Phase of Chronic Myeloid Leukemia in Qatar: A Cost-Effectiveness Analysis
by: Ahmad Adel MSc, et al.
Published: (2021-04-01)

The Potential Diagnostic Accuracy of Circulating MicroRNAs for Leukemia: A Meta-Analysis
by: Wen-Ting Zhang MD, PhD(c), et al.
Published: (2021-04-01)

Schnitzler syndrome associated with hairy cell leukemia presenting with chronic urticaria and arthralgias
by: Hélène Fank, MD, et al.
Published: (2018-05-01)

Educational Case: Acute Promyelocytic Leukemia With
by: Rebecca L. Kunak DO, et al.
Published: (2019-09-01)

Acute Myeloid Leukemia Associated Leukocytic Hypophysitis Presenting with Central Diabetes Insipidus
by: Joshua A. Levine, MD, PhD, et al.
Published: (2018-11-01)

Bilateral macular detachment: Choroid as a sanctuary of acute lymphoblastic leukemia
by: Agustina Adaniya, MD, et al.
Published: (2020-09-01)

Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia
by: Benjamin Arthurs, MD, et al.
Published: (2017-01-01)

Pediatric Philadelphia-positive B lymphoblastic leukemia with CD56 expression and L2 morphology: Case report and review of the literature
by: Jadee Neff, MD, PhD, et al.
Published: (2017-06-01)

Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)
by: Hawraa Shwaylia, et al.
Published: (2021-06-01)

Outcome of Pregnancy in the Era of Pegylated Interferon Alpha 2a in Females with Essential Thrombocythemia: An Experience from Qatar
by: Mohammad Abu-Tineh, et al.
Published: (2020-03-01)

Acute Lymphoblastic Leukemia in a Man Treated With Fingolimod for Relapsing Multiple Sclerosis
by: Stanley Cohan MD, PhD, et al.
Published: (2015-03-01)

Whole-Body Distribution of Leukemia and Functional Total Marrow Irradiation Based on FLT-PET and Dual-Energy CT
by: Taiki Magome PhD, et al.
Published: (2017-09-01)

Feasibility and Potential Benefits of an Exercise Intervention in a Male With Down Syndrome Undergoing High-Dose Chemotherapy for Acute Lymphoblastic Leukemia: A Case Report
by: Linda Bühl BSc, et al.
Published: (2019-02-01)

Pathologically Proven Intraocular Infiltration With Adult T-Cell Leukemia/Lymphoma: Two New Cases With Either Vitreous Opacity or Aqueous Hypopyon and Literature Review of 16 Cases
by: Toshihiko Matsuo MD, PhD, et al.
Published: (2020-10-01)

Leukemia cutis mimicking tumid lupus as the presenting sign in a case of mixed T/B-cell acute lymphoblastic leukemia
by: Renee M. Thomas, MD, PhD, et al.
Published: (2020-07-01)

Acute Myelogenous Leukemia With Trisomy 8 and Concomitant Acquired Factor VII Deficiency
by: Leila Moosavi MD, et al.
Published: (2019-09-01)

Autoimmune Ataxia During Maintenance Therapy for Acute Lymphoblastic Leukemia
by: Julie Voeller MD, et al.
Published: (2018-12-01)

Mast Cell Leukemia: Review of a Rare Disease and Case Report of Prolonged Survival after Allogeneic Stem Cell Transplant
by: James Bauer, MD, PhD, et al.
Published: (2017-11-01)

Is Adherence to Imatinib Mesylate Treatment among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?
by: Nader I. Al-Dewik, et al.
Published: (2016-01-01)

The Solute Carrier Family 2 Genes Are Potential Prognostic Biomarkers in Acute Myeloid Leukemia
by: Binbin Lai MD, et al.
Published: (2020-01-01)

An Unusual Case of Prolymphocytic Leukemia Transformation in a Patient With Chronic Lymphocytic Leukemia
by: Stephen Bell MD, et al.
Published: (2021-01-01)

Concomitant BCR-ABL1 positive chronic myelogenous leukemia emerging in a patient with MPL W515L associated primary myelofibrosis
by: Juan C. Gomez-Gelvez, MD, et al.
Published: (2016-03-01)

Applications of PET in Diagnosis and Prognosis of Leukemia
by: Zixuan Zhao MB, et al.
Published: (2020-09-01)

Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?
by: Nader I. Al-Dewik, et al.
Published: (2016-10-01)

Propofol enhances BCR-ABL TKIs’ inhibitory effects in chronic myeloid leukemia through Akt/mTOR suppression
by: Zhimin Tan, et al.
Published: (2017-09-01)

A Case of Chronic Neutrophilic Leukemia Successfully Treated with Pegylated Interferon Alpha-2a
by: Mohamed A. Yassin, et al.
Published: (2015-01-01)

A Case of Chronic Neutrophilic Leukemia Successfully Treated with Pegylated Interferon Alpha-2a
by: Mohamed A. Yassin, et al.
Published: (2015-04-01)